Clayton Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.27M | Sell |
46,748
-4,890
| -9% | -$342K | 2.74% | 15 |
|
|
2025
Q1 | $3.8M | Buy |
51,638
+5,695
| +12% | +$419K | 3.3% | 10 |
|
|
2024
Q4 | $3.01M | Sell |
45,943
-285
| -0.6% | -$18.7K | 2.08% | 21 |
|
|
2024
Q3 | $3.6M | Sell |
46,228
-314
| -0.7% | -$24.5K | 2.59% | 17 |
|
|
2024
Q2 | $3.63M | Buy |
46,542
+9,668
| +26% | +$754K | 2.92% | 13 |
|
|
2024
Q1 | $2.5M | Buy |
+36,874
| New | +$2.5M | 2.12% | 22 |
|